These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19523465)

  • 21. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
    Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
    J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin is associated with bone mineral density in perimenopausal women.
    Jürimäe J; Rembel K; Jürimäe T; Rehand M
    Horm Metab Res; 2005 May; 37(5):297-302. PubMed ID: 15971153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of adiponectin and sex steroid hormones on bone mineral density and bone formation markers in postmenopausal women with subclinical hyperthyroidism.
    Ahn KH; Lee SH; Park HT; Kim T; Hur JY; Kim YT; Kim SH
    J Obstet Gynaecol Res; 2010 Apr; 36(2):370-6. PubMed ID: 20492390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
    Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure.
    Tsutamoto T; Tanaka T; Sakai H; Ishikawa C; Fujii M; Yamamoto T; Horie M
    Eur Heart J; 2007 Jul; 28(14):1723-30. PubMed ID: 17507366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women.
    D'Amore M; Fanelli M; D'Amore S; Fontana A; Minenna G
    Panminerva Med; 2006 Dec; 48(4):215-21. PubMed ID: 17215793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of acute hyperinsulinaemia on total and high-molecular-weight adiponectin concentration in metabolically healthy but obese postmenopausal women: a Montreal-Ottawa New Emerging Team (MONET) study.
    Elisha B; Karelis AD; Imbeault P; Rabasa-Lhoret R
    Diabetes Metab; 2010 Sep; 36(4):319-21. PubMed ID: 20605505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women.
    Uemura H; Yasui T; Miyatani Y; Yamada M; Hiyoshi M; Arisawa K; Irahara M
    Menopause; 2008; 15(1):180-4. PubMed ID: 17545921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
    Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
    Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women.
    Oh KW; Rhee EJ; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Choi MG; Yoo HJ; Park SW
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):244-9. PubMed ID: 15272921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum adiponectin, bone mineral density and bone turnover markers in post-menopausal women with newly diagnosed Type 2 diabetes: a 12-month follow-up.
    Miazgowski T; Noworyta-Ziętara M; Safranow K; Ziemak J; Widecka K
    Diabet Med; 2012 Jan; 29(1):62-9. PubMed ID: 21726281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
    J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women.
    Sahin G; Polat G; Baethiş S; Milcan A; Baethdatoethlu O; Erdoethan C; Camdeviren H
    Rheumatol Int; 2003 Mar; 23(2):87-91. PubMed ID: 12634942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoprotegerin and nuclear factor-kappaB ligand are associated with leptin and adiponectin levels, in apparently healthy women.
    Tenta R; Panagiotakos DB; Fragopoulou E; Nomikos T; Pitsavos C; Chrysohoou C; Antonopoulou S; Stefanadis C
    J Musculoskelet Neuronal Interact; 2010 Jun; 10(2):174-9. PubMed ID: 20516635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interrelationships of serum estradiol, estrone, and estrone sulfate, adiposity, biochemical bone markers, and leptin in post-menopausal women.
    Castracane VD; Kraemer GR; Ogden BW; Kraemer RR
    Maturitas; 2006 Jan; 53(2):217-25. PubMed ID: 15913927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.
    Yano K; Tsuda E; Washida N; Kobayashi F; Goto M; Harada A; Ikeda K; Higashio K; Yamada Y
    J Bone Miner Res; 1999 Apr; 14(4):518-27. PubMed ID: 10234572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.